| Veitla Sankeertha Rao, MD | |
|
3003 W Good Hope Rd, Milwaukee, WI 53209-2042 | |
| (414) 352-3100 | |
| Not Available |
| Full Name | Veitla Sankeertha Rao |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 17 Years |
| Location | 3003 W Good Hope Rd, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013148204 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301095009 (Michigan) | Secondary |
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 62024-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center - Grafton | Grafton, WI | Hospital |
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Aurora Sheboygan Memorial Medical Ctr | Sheboygan, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Advanced Healthcare Inc | 3375625833 | 929 |
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
States that expanded eligibility for their Medicaid program in 2014 when the Affordable Care Act was implemented, saw fewer uninsured patients among major cardiac-related hospitalizations in the first year compared with states that did not expand the program, according to a study released today in JAMA Network Open.
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
The Canadian Syncope Risk Score (CSRS) is an accurate validated prediction score for emergency department patients with unexplained syncope.
A new study in Biological Psychiatry reports that dementia-related and psychiatric-related proteins cluster together to form aggregates in the brain, leading to abnormal cell function and behavior.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 2 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
States that expanded eligibility for their Medicaid program in 2014 when the Affordable Care Act was implemented, saw fewer uninsured patients among major cardiac-related hospitalizations in the first year compared with states that did not expand the program, according to a study released today in JAMA Network Open.
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
The Canadian Syncope Risk Score (CSRS) is an accurate validated prediction score for emergency department patients with unexplained syncope.
A new study in Biological Psychiatry reports that dementia-related and psychiatric-related proteins cluster together to form aggregates in the brain, leading to abnormal cell function and behavior.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 2 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
States that expanded eligibility for their Medicaid program in 2014 when the Affordable Care Act was implemented, saw fewer uninsured patients among major cardiac-related hospitalizations in the first year compared with states that did not expand the program, according to a study released today in JAMA Network Open.
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
The Canadian Syncope Risk Score (CSRS) is an accurate validated prediction score for emergency department patients with unexplained syncope.
A new study in Biological Psychiatry reports that dementia-related and psychiatric-related proteins cluster together to form aggregates in the brain, leading to abnormal cell function and behavior.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Veitla Sankeertha Rao, MD 3003 W Good Hope Rd, Milwaukee, WI 53209-2042 Ph: (414) 352-3100 | Veitla Sankeertha Rao, MD 3003 W Good Hope Rd, Milwaukee, WI 53209-2042 Ph: (414) 352-3100 |
News Archive
States that expanded eligibility for their Medicaid program in 2014 when the Affordable Care Act was implemented, saw fewer uninsured patients among major cardiac-related hospitalizations in the first year compared with states that did not expand the program, according to a study released today in JAMA Network Open.
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
The Canadian Syncope Risk Score (CSRS) is an accurate validated prediction score for emergency department patients with unexplained syncope.
A new study in Biological Psychiatry reports that dementia-related and psychiatric-related proteins cluster together to form aggregates in the brain, leading to abnormal cell function and behavior.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 2 days ago
Julia Bonner, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Rasika Surajyam Chepuri, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 | |
Soryal A Soryal, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233 Phone: 414-219-7300 | |
Aboud Affi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1218 W Kilbourn Ave, Suite 404, Milwaukee, WI 53233 Phone: 414-291-3100 |